A open-label, randomized, parallel, phase III trial to evaluate the efficacy and safety of Genexol (R)-PM compared to Genexol (R)(conventional paclitaxel with cremorphor EL) in recurrent or metastatic breast cancer patients
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.